| Year |
Citation |
Score |
| 2023 |
Kiliti AJ, Sharif GM, Martin MB, Wellstein A, Riegel AT. AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer. Frontiers in Endocrinology. 14: 1250218. PMID 37711895 DOI: 10.3389/fendo.2023.1250218 |
0.421 |
|
| 2023 |
Kiliti AJ, Sharif GM, Wellstein A, Riegel AT. Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis. Oncotarget. 14: 780-781. PMID 37646773 DOI: 10.18632/oncotarget.28452 |
0.41 |
|
| 2023 |
Yuan M, Barefoot ME, Peterson K, Campbell MJ, Blancato JK, Chen M, Schmidt MO, Kiliti AJ, Fang HB, Wellstein A, Riegel AT, Sharif GM. Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 24. PMID 37511268 DOI: 10.3390/ijms241411505 |
0.468 |
|
| 2023 |
Gallanis GT, Sharif GM, Schmidt MO, Friedland BN, Battina R, Rahhal R, Davis JE, Khan IS, Wellstein A, Riegel AT. Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells. Cancers. 15. PMID 36980794 DOI: 10.3390/cancers15061908 |
0.345 |
|
| 2022 |
Sharif GM, Der L, Riegel AT, Paranjape M, Wellstein A. Real-Time Detection and Capture of Invasive Cell Subpopulations from Co-cultures. Journal of Visualized Experiments : Jove. PMID 35435909 DOI: 10.3791/63512 |
0.343 |
|
| 2022 |
Lin YN, Schmidt MO, Sharif GM, Vietsch EE, Kiliti AJ, Barefoot ME, Riegel AT, Wellstein A. Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity. Oncoimmunology. 11: 2027136. PMID 35127250 DOI: 10.1080/2162402X.2022.2027136 |
0.311 |
|
| 2021 |
Sharif GM, Campbell MJ, Nasir A, Sengupta S, Graham GT, Kushner MH, Kietzman WB, Schmidt MO, Pearson GW, Loudig O, Fineberg S, Wellstein A, Riegel AT. An AIB1 isoform alters enhancer access and enables progression of early stage triple-negative breast cancer. Cancer Research. PMID 34135000 DOI: 10.1158/0008-5472.CAN-20-3625 |
0.462 |
|
| 2020 |
Gallanis GT, Pericas RI, Riegel AT, Pohlmann PR. An evaluation of palbociclib as a breast cancer treatment option: a current update. Expert Opinion On Pharmacotherapy. 1-10. PMID 33198527 DOI: 10.1080/14656566.2020.1838485 |
0.4 |
|
| 2020 |
Westcott JM, Camacho S, Nasir A, Huysman ME, Rahhal R, Dang TT, Riegel AT, Brekken RA, Pearson GW. ΔNp63 regulated epithelial-to-mesenchymal transition state heterogeneity confers a leader-follower relationship that drives collective invasion. Cancer Research. PMID 32661136 DOI: 10.1158/0008-5472.Can-20-0014 |
0.388 |
|
| 2020 |
Lin YN, Nasir A, Camacho S, Berry DL, Schmidt MO, Pearson GW, Riegel AT, Wellstein A. Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture. Journal of Visualized Experiments : Jove. PMID 32658183 DOI: 10.3791/61392 |
0.424 |
|
| 2020 |
Kushner MH, Graham G, Sharif G, Kietzman W, Glasgow E, Sangupta S, Wellstein A, Riegel AT. Abstract B41: Role of AIB1 in YAP-TEAD signaling in the progression of early-stage breast cancer Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-B41 |
0.509 |
|
| 2019 |
Kushner MH, Ory V, Graham GT, Sharif GM, Kietzman WB, Thevissen S, Yuan M, Schmidt MO, Wellstein A, Riegel AT. Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. Embo Reports. e48741. PMID 31788936 DOI: 10.15252/Embr.201948741 |
0.537 |
|
| 2019 |
Kietzman WB, Graham GT, Ory V, Sharif G, Kushner MH, Gallanis GT, Kallakury B, Wellstein A, Riegel AT. Short and long-term effects of CDK4/6 inhibition on early stage breast cancer. Molecular Cancer Therapeutics. PMID 31451564 DOI: 10.1158/1535-7163.Mct-19-0231 |
0.517 |
|
| 2019 |
Saenz FR, Ory V, Schmidt MO, Kallakury BV, Mueller SC, Furth PA, Wellstein A, Riegel AT. Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer. Neoplasia (New York, N.Y.). 21: 963-973. PMID 31437536 DOI: 10.1016/J.Neo.2019.07.001 |
0.552 |
|
| 2019 |
Deslattes Mays A, Schmidt M, Graham G, Tseng E, Baybayan P, Sebra R, Sanda M, Mazarati JB, Riegel A, Wellstein A. Single-Molecule Real-Time (SMRT) Full-Length RNA-Sequencing Reveals Novel and Distinct mRNA Isoforms in Human Bone Marrow Cell Subpopulations. Genes. 10. PMID 30934798 DOI: 10.3390/Genes10040253 |
0.343 |
|
| 2018 |
Ory V, Kietzman WB, Boeckelman J, Kallakury BV, Wellstein A, Furth PA, Riegel AT. The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Research and Treatment. PMID 29350308 DOI: 10.1007/S10549-017-4649-Y |
0.332 |
|
| 2018 |
Saenz FR, Wellstein A, Riegel AT. Abstract A35: Characterizing the role of the nuclear coactivator AIB1 in triple-negative breast cancer Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-A35 |
0.565 |
|
| 2017 |
Tassi E, Lai EY, Li L, Solis G, Chen Y, Kietzman WE, Ray PE, Riegel AT, Welch WJ, Wilcox CS, Wellstein A. Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein). Hypertension (Dallas, Tex. : 1979). PMID 29158353 DOI: 10.1161/Hypertensionaha.117.10268 |
0.406 |
|
| 2017 |
Schmidt MO, Garman KA, Lee YG, Zuo C, Beck PJ, Tan M, Aguilar-Pimentel JA, Ollert M, Schmidt-Weber C, Fuchs H, Gailus-Durner V, Hrabe de Angelis M, Tassi E, Riegel AT, et al. The Role of Fibroblast Growth Factor Binding Protein 1 in Skin Carcinogenesis and Inflammation. The Journal of Investigative Dermatology. PMID 28864076 DOI: 10.1016/J.Jid.2017.07.847 |
0.429 |
|
| 2017 |
Berens EB, Gilardi M, Moretti M, Riegel AT, Wellstein A. Abstract 908: A role for MST4 in organelle organization and breast cancer cell vascular invasion Cancer Research. 77: 908-908. DOI: 10.1158/1538-7445.Am2017-908 |
0.482 |
|
| 2017 |
Lin K, Grivas C, Boru E, Dayani Y, Berens E, Riegel AT, Glasgow E, Yarden RI. Abstract 5122: Utilizing zebrafish to study the effect strigolactone on breast cancer cells Cancer Research. 77: 5122-5122. DOI: 10.1158/1538-7445.Am2017-5122 |
0.518 |
|
| 2017 |
Sharif GM, Ory V, Wellstein A, Riegel A. Abstract 4864: Role of AIB1 Δ -4 in malignant progression of breast cancer Cancer Research. 77: 4864-4864. DOI: 10.1158/1538-7445.Am2017-4864 |
0.465 |
|
| 2017 |
Kietzman WB, Ory V, Saenz F, Sharif G, Wellstein A, Riegel AT. Abstract 2357: CDK4/6 inhibition in early stage triple negative breast cancer Cancer Research. 77: 2357-2357. DOI: 10.1158/1538-7445.Am2017-2357 |
0.415 |
|
| 2016 |
Berens EB, Sharif GM, Schmidt MO, Yan G, Shuptrine CW, Weiner LM, Glasgow E, Riegel AT, Wellstein A. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. PMID 27375028 DOI: 10.1038/Onc.2016.234 |
0.502 |
|
| 2016 |
Saenz FR, Riegel AT. Abstract C63: Elucidating the role of AIB1 in triple-negative breast cancer cell lines Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-C63 |
0.547 |
|
| 2016 |
Berens EB, Sharif GM, Schmidt MO, Shuptrine CW, Weiner LM, Glasgow E, Riegel AT, Wellstein A. Abstract B44: Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-B44 |
0.487 |
|
| 2016 |
Sharif GM, Schmidt MO, Shuptrine C, Louis WM, Riegel AT, Wellstein A. Abstract A15: SMC2 role in regulating tumor angiogenesis via FGF signaling Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-A15 |
0.484 |
|
| 2015 |
Berens EB, Holy JM, Riegel AT, Wellstein A. A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting. Journal of Visualized Experiments : Jove. PMID 26649463 DOI: 10.3791/53409 |
0.405 |
|
| 2015 |
Sharif GM, Schmidt MO, Yi C, Hu Z, Haddad BR, Glasgow E, Riegel AT, Wellstein A. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling. Oncogene. PMID 25772246 DOI: 10.1038/Onc.2015.44 |
0.492 |
|
| 2014 |
Saenz FR, Ory V, AlOtaiby M, Rosenfield S, Furlong M, Cavalli LR, Johnson MD, Liu X, Schlegel R, Wellstein A, Riegel AT. Conditionally reprogrammed normal and transformed mouse mammary epithelial cells display a progenitor-cell-like phenotype. Plos One. 9: e97666. PMID 24831228 DOI: 10.1371/Journal.Pone.0097666 |
0.402 |
|
| 2014 |
Garee JP, Chien CD, Li JV, Wellstein A, Riegel AT. Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex. Molecular Endocrinology (Baltimore, Md.). 28: 846-59. PMID 24678732 DOI: 10.1210/Me.2013-1379 |
0.715 |
|
| 2014 |
Ory V, Tassi E, Cavalli LR, Sharif GM, Saenz F, Baker T, Schmidt MO, Mueller SC, Furth PA, Wellstein A, Riegel AT. The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ. Oncogene. 33: 3033-42. PMID 23851504 DOI: 10.1038/Onc.2013.263 |
0.535 |
|
| 2013 |
Li JV, Chien CD, Garee JP, Xu J, Wellstein A, Riegel AT. Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 27: 1113-27. PMID 23660594 DOI: 10.1210/Me.2012-1353 |
0.751 |
|
| 2013 |
Sharif GM, Schmidt MO, Hu Z, Glasgow E, Riegel AT, Wellstein A. Abstract B63: Cancer cell invasion determined by cell density-dependent, cytokine-mediated crosstalk Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B63 |
0.516 |
|
| 2013 |
Sharif GM, Schmidt MO, Shuptrine C, Weiner LM, Hu Z, Riegel AT, Wellstein A. Abstract 2689: Drivers of cancer cell invasion and metastasis. Cancer Research. 73: 2689-2689. DOI: 10.1158/1538-7445.Am2013-2689 |
0.471 |
|
| 2013 |
Ory V, Tassi E, Cavalli L, Saenz F, Baker T, Mueller S, Furth P, Wellstein A, Riegel A. Abstract 1404: The nuclear coactivator amplified in breast cancer 1 promotes the initiation and the development of ductal carcinomain situ. Cancer Research. 73: 1404-1404. DOI: 10.1158/1538-7445.Am2013-1404 |
0.538 |
|
| 2013 |
Ory V, Tassi E, Cavalli L, Sharif G, Saenz F, Baker T, Schmidt M, Mueller S, Furth P, Wellstein A, Riegel A. Abstract P5-07-03: The nuclear coactivator amplified in breast cancer 1 maintains tumor initiating cells during development of ductal carcinoma in situ Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-07-03 |
0.481 |
|
| 2012 |
Rosenfield SM, Bowden ET, Cohen-Missner S, Gibby KA, Ory V, Henke RT, Riegel AT, Wellstein A. Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells. Plos One. 7: e47876. PMID 23077670 DOI: 10.1371/Journal.Pone.0047876 |
0.441 |
|
| 2012 |
Al-Otaiby M, Tassi E, Schmidt MO, Chien CD, Baker T, Salas AG, Xu J, Furlong M, Schlegel R, Riegel AT, Wellstein A. Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing. The American Journal of Pathology. 180: 1474-84. PMID 22342158 DOI: 10.1016/J.Ajpath.2011.12.032 |
0.708 |
|
| 2012 |
Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, Timofeeva OA, Nealon C, Dakic A, Simic V, Haddad BR, Rhim JS, Dritschilo A, Riegel A, McBride A, et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. The American Journal of Pathology. 180: 599-607. PMID 22189618 DOI: 10.1016/J.Ajpath.2011.10.036 |
0.405 |
|
| 2011 |
Tassi E, McDonnell K, Gibby KA, Tilan JU, Kim SE, Kodack DP, Schmidt MO, Sharif GM, Wilcox CS, Welch WJ, Gallicano GI, Johnson MD, Riegel AT, Wellstein A. Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. The American Journal of Pathology. 179: 2220-32. PMID 21945411 DOI: 10.1016/J.Ajpath.2011.07.043 |
0.443 |
|
| 2011 |
Hu ZZ, Kagan BL, Ariazi EA, Rosenthal DS, Zhang L, Li JV, Huang H, Wu C, Jordan VC, Riegel AT, Wellstein A. Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells. Plos One. 6: e20410. PMID 21738574 DOI: 10.1371/Journal.Pone.0020410 |
0.684 |
|
| 2011 |
Chien CD, Kirilyuk A, Li JV, Zhang W, Lahusen T, Schmidt MO, Oh AS, Wellstein A, Riegel AT. Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription. The Journal of Biological Chemistry. 286: 26813-27. PMID 21636853 DOI: 10.1074/Jbc.M110.216200 |
0.735 |
|
| 2011 |
Nakles RE, Shiffert MT, Díaz-Cruz ES, Cabrera MC, Alotaiby M, Miermont AM, Riegel AT, Furth PA. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content. Molecular Endocrinology (Baltimore, Md.). 25: 549-63. PMID 21292825 DOI: 10.1210/me.2010-0114 |
0.462 |
|
| 2011 |
Al-Otaiby MA, Zhangzhi H, Riegel A, Wellstein A. Abstract 3115: Role of nuclear coactivator AIB1 in endothelial cell function and angiogenesis Cancer Research. 71: 3115-3115. DOI: 10.1158/1538-7445.Am2011-3115 |
0.774 |
|
| 2010 |
Peran I, Riegel A, Dai Y, Schlegel R, Liu X. Is HPV-18 present in human breast cancer cell lines? British Journal of Cancer. 102: 1549-1550. PMID 20407441 DOI: 10.1038/Sj.Bjc.6605671 |
0.332 |
|
| 2010 |
LaConti JJ, Shivapurkar N, Preet A, Kim SE, Riegel AT, Wellstein A. Abstract 721: An anaplastic lymphoma kinase antibody targets pancreatic allografts, prevents the progression of pancreatic cancer, and induces changes in microRNA expression Cancer Research. 70: 721-721. DOI: 10.1158/1538-7445.Am10-721 |
0.345 |
|
| 2009 |
Stylianou DC, Auf der Maur A, Kodack DP, Henke RT, Hohn S, Toretsky JA, Riegel AT, Wellstein A. Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor. Oncogene. 28: 3296-306. PMID 19633684 DOI: 10.1038/Onc.2009.184 |
0.407 |
|
| 2009 |
Lahusen T, Henke RT, Kagan BL, Wellstein A, Riegel AT. The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer. Breast Cancer Research and Treatment. 116: 225-37. PMID 19418218 DOI: 10.1007/S10549-009-0405-2 |
0.545 |
|
| 2009 |
Katiyar P, Ma Y, Riegel A, Fan S, Rosen EM. Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. Molecular Endocrinology (Baltimore, Md.). 23: 1135-46. PMID 19389812 DOI: 10.1210/me.2008-0347 |
0.348 |
|
| 2008 |
Oh AS, Lahusen JT, Chien CD, Fereshteh MP, Zhang X, Dakshanamurthy S, Xu J, Kagan BL, Wellstein A, Riegel AT. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Molecular and Cellular Biology. 28: 6580-93. PMID 18765637 DOI: 10.1128/Mcb.00118-08 |
0.724 |
|
| 2008 |
Zhang W, Chen Y, Swift MR, Tassi E, Stylianou DC, Gibby KA, Riegel AT, Wellstein A. Effect of FGF-binding protein 3 on vascular permeability. The Journal of Biological Chemistry. 283: 28329-37. PMID 18669637 DOI: 10.1074/Jbc.M802144200 |
0.382 |
|
| 2008 |
Fereshteh MP, Tilli MT, Kim SE, Xu J, O'Malley BW, Wellstein A, Furth PA, Riegel AT. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Research. 68: 3697-706. PMID 18483252 DOI: 10.1158/0008-5472.Can-07-6702 |
0.537 |
|
| 2008 |
Tilli MT, Fereshteh MP, Torre KM, Riegel AT, Furth PA. The Role of the Estrogen Receptor Coactivator, Amplified in Breast Cancer 1 (AIB1), in Her2/neu-Initiated Mouse Mammary Carcinogenesis and Tamoxifen Resistance. Biology of Reproduction. 78: 103-103. DOI: 10.1093/Biolreprod/78.S1.103D |
0.483 |
|
| 2007 |
Lahusen T, Fereshteh M, Oh A, Wellstein A, Riegel AT. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Research. 67: 7256-65. PMID 17671194 DOI: 10.1158/0008-5472.Can-07-1013 |
0.473 |
|
| 2007 |
Ma Y, Hu C, Riegel AT, Fan S, Rosen EM. Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity. Molecular Endocrinology (Baltimore, Md.). 21: 1905-23. PMID 17505062 DOI: 10.1210/Me.2006-0397 |
0.39 |
|
| 2007 |
Kuo AH, Stoica GE, Riegel AT, Wellstein A. Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase. Oncogene. 26: 859-69. PMID 16878150 DOI: 10.1038/Sj.Onc.1209840 |
0.38 |
|
| 2007 |
Jordan VC, Ariazi EA, Lewis-Wambi JS, Swaby RR, Cunliffe HE, Riegel AT, Wellstein A. Oestrogen is bad for patients with breast cancer? Breast Cancer Research. 9. DOI: 10.1186/Bcr1820 |
0.463 |
|
| 2006 |
Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL, Weissman AM, Schlegel R, Wellstein A, Riegel AT. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Research. 66: 8680-6. PMID 16951183 DOI: 10.1158/0008-5472.Can-06-0557 |
0.524 |
|
| 2006 |
Briones VR, Chen S, Riegel AT, Lechleider RJ. Mechanism of fibroblast growth factor-binding protein 1 repression by TGF-beta. Biochemical and Biophysical Research Communications. 345: 595-601. PMID 16690027 DOI: 10.1016/J.Bbrc.2006.04.052 |
0.343 |
|
| 2006 |
Xie B, Tassi E, Swift MR, McDonnell K, Bowden ET, Wang S, Ueda Y, Tomita Y, Riegel AT, Wellstein A. Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display. The Journal of Biological Chemistry. 281: 1137-44. PMID 16257968 DOI: 10.1074/Jbc.M510754200 |
0.33 |
|
| 2005 |
McDonnell K, Bowden ET, Cabal-Manzano R, Hoxter B, Riegel AT, Wellstein A. Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 747-55. PMID 15806140 DOI: 10.1038/Labinvest.3700269 |
0.41 |
|
| 2005 |
Tilli MT, Reiter R, Oh AS, Henke RT, McDonnell K, Gallicano GI, Furth PA, Riegel AT. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice Molecular Endocrinology. 19: 644-656. PMID 15550471 DOI: 10.1210/Me.2004-0106 |
0.561 |
|
| 2005 |
Malerczyk C, Schulte AM, Czubayko F, Bellon L, Macejak D, Riegel AT, Wellstein A. Ribozyme targeting of the growth factor pleiotrophin in established tumors: A gene therapy approach Gene Therapy. 12: 339-346. PMID 15496960 DOI: 10.1038/Sj.Gt.3302398 |
0.39 |
|
| 2004 |
Oh A, List HJ, Reiter R, Mani A, Zhang Y, Gehan E, Wellstein A, Riegel AT. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Research. 64: 8299-308. PMID 15548698 DOI: 10.1158/0008-5472.Can-04-0354 |
0.572 |
|
| 2004 |
Henke RT, Haddad BR, Kim SE, Rone JD, Mani A, Jessup JM, Wellstein A, Maitra A, Riegel AT. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6134-42. PMID 15448000 DOI: 10.1158/1078-0432.Ccr-04-0561 |
0.521 |
|
| 2004 |
Bowden ET, Riegel AT. Tetracycline-regulated expression of hammerhead ribozymes in vivo. Methods in Molecular Biology (Clifton, N.J.). 252: 179-94. PMID 15017049 DOI: 10.1385/1-59259-746-7:179 |
0.39 |
|
| 2004 |
Reiter R, Oh AS, Wellstein A, Riegel AT. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity. Oncogene. 23: 403-9. PMID 14691461 DOI: 10.1038/Sj.Onc.1207202 |
0.468 |
|
| 2003 |
Kagan BL, Henke RT, Cabal-Manzano R, Stoica GE, Nguyen Q, Wellstein A, Riegel AT. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Research. 63: 1696-705. PMID 12670924 |
0.441 |
|
| 2002 |
Lauritsen KJ, List HJ, Reiter R, Wellstein A, Riegel AT. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells. Oncogene. 21: 7147-55. PMID 12370804 DOI: 10.1038/Sj.Onc.1205943 |
0.523 |
|
| 2002 |
Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT, Wellstein A. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. The Journal of Biological Chemistry. 277: 35990-8. PMID 12122009 DOI: 10.1074/Jbc.M205749200 |
0.454 |
|
| 2001 |
List HJ, Reiter R, Singh B, Wellstein A, Riegel AT. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue Breast Cancer Research and Treatment. 68: 21-28. PMID 11678305 DOI: 10.1023/A:1017910924390 |
0.47 |
|
| 2001 |
Reiter R, Wellstein A, Riegel AT. An Isoform of the Coactivator AIB1 that Increases Hormone and Growth Factor Sensitivity Is Overexpressed in Breast Cancer Journal of Biological Chemistry. 276: 39736-39741. PMID 11502741 DOI: 10.1074/Jbc.M104744200 |
0.554 |
|
| 2001 |
List HJ, Lauritsen KJ, Reiter R, Powers C, Wellstein A, Riegel AT. Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells Journal of Biological Chemistry. 276: 23763-23768. PMID 11328819 DOI: 10.1074/Jbc.M102397200 |
0.57 |
|
| 2001 |
Stoica GE, Kuo A, Aigner A, Sunitha I, Souttou B, Malerczyk C, Caughey DJ, Wen D, Karavanov A, Riegel AT, Wellstein A. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. The Journal of Biological Chemistry. 276: 16772-9. PMID 11278720 DOI: 10.1074/Jbc.M010660200 |
0.463 |
|
| 2000 |
Boyle BJ, Harris VK, Liaudet-Coopman EDE, Riegel AT, Wellstein A. Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acid Biochemical Pharmacology. 60: 1677-1684. PMID 11077050 DOI: 10.1016/S0006-2952(00)00507-4 |
0.43 |
|
| 2000 |
List HJ, Smith CL, Martinez E, Harris VK, Danielsen M, Riegel AT. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter Experimental Cell Research. 260: 160-165. PMID 11010820 DOI: 10.1006/Excr.2000.5018 |
0.416 |
|
| 2000 |
Schulte AM, Malerczyk C, Cabal-Manzano R, Gajarsa JJ, List HJ, Riegel AT, Wellstein A. Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: A critical role of a retroviral Sp1-binding site Oncogene. 19: 3988-3998. PMID 10962555 DOI: 10.1038/Sj.Onc.1203742 |
0.407 |
|
| 2000 |
Harris VK, Coticchia CM, List HJ, Wellstein A, Riegel AT. Mitogen-induced expression of the fibroblast growth factor-binding protein is transcriptionally repressed through a non-canonical E-box element Journal of Biological Chemistry. 275: 28539-28548. PMID 10871606 DOI: 10.1074/Jbc.M001677200 |
0.432 |
|
| 2000 |
Harris VK, Coticchia CM, Kagan BL, Ahmad S, Wellstein A, Riegel AT. Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways. The Journal of Biological Chemistry. 275: 10802-11. PMID 10753873 DOI: 10.1074/Jbc.275.15.10802 |
0.441 |
|
| 1999 |
Meighan-Mantha RL, Riegel AT, Suy S, Harris V, Wang FH, Lozano C, Whiteside TL, Kasid U. Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells. Molecular and Cellular Biochemistry. 199: 209-15. PMID 10544969 DOI: 10.1023/A:1006958217143 |
0.428 |
|
| 1999 |
List HJ, Smith CL, Rodriguez O, Danielsen M, Riegel AT. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: An explanation for trichostatin a effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter Experimental Cell Research. 252: 471-478. PMID 10527637 DOI: 10.1006/Excr.1999.4638 |
0.38 |
|
| 1999 |
List HJ, Lozano C, Lu J, Danielsen M, Wellstein A, Riegel AT. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor Experimental Cell Research. 250: 414-422. PMID 10413595 DOI: 10.1006/Excr.1999.4517 |
0.401 |
|
| 1998 |
Harris VK, Liaudet-Coopman EDE, Boyle BJ, Wellstein A, Riegel AT. Phorbol ester-induced transcription of a fibroblast growth factor- binding protein is modulated by a complex interplay of positive and negative regulatory promoter elements Journal of Biological Chemistry. 273: 19130-19139. PMID 9668098 DOI: 10.1074/Jbc.273.30.19130 |
0.439 |
|
| 1998 |
Bonovich MT, List HJ, Zhang S, Danielsen M, Riegel AT. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome Experimental Cell Research. 239: 454-462. PMID 9521864 DOI: 10.1006/Excr.1997.3920 |
0.375 |
|
| 1997 |
Meighan-Mantha RL, Wellstein A, Riegel AT. Differential regulation of extracellular signal-regulated kinase 1 and 2 activity during 12-O-tetradecanoylphorbol 13-acetate-induced differentiation of HL-60 cells Experimental Cell Research. 234: 321-328. PMID 9260900 DOI: 10.1006/Excr.1997.3631 |
0.337 |
|
| 1997 |
Souttou B, Ahmad S, Riegel AT, Wellstein A. Signal transduction pathways involved in the mitogenic activity of pleiotrophin Journal of Biological Chemistry. 272: 19588-19593. PMID 9235965 DOI: 10.1074/Jbc.272.31.19588 |
0.312 |
|
| 1997 |
Davis AF, Meighan-Mantha RL, Riegel AT. Effects of TPA, bryostatin 1, and retinoic acid on PO-B, AP-1, and AP-2 DNA binding during HL-60 differentiation. Journal of Cellular Biochemistry. 65: 308-24. PMID 9138088 DOI: 10.1002/(Sici)1097-4644(19970601)65:3<308::Aid-Jcb2>3.0.Co;2-W |
0.331 |
|
| 1996 |
Schulte AM, Lai S, Kurtz A, Czubayko F, Riegel AT, Wellstein A. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus Proceedings of the National Academy of Sciences of the United States of America. 93: 14759-14764. PMID 8962128 DOI: 10.1073/Pnas.93.25.14759 |
0.4 |
|
| 1993 |
Buchert ET, Woosley RL, Swain SM, Oliver SJ, Coughlin SS, Pickle L, Trock B, Riegel AT. Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics. 3: 322-7. PMID 8148873 DOI: 10.1097/00008571-199312000-00006 |
0.424 |
|
| 1992 |
Lai S, Czubayko F, Riegel AT, Wellstein A. Structure of the human heparin-binding growth factor gene pleiotrophin Biochemical and Biophysical Research Communications. 187: 1113-1122. PMID 1530608 DOI: 10.1016/0006-291X(92)91312-E |
0.34 |
|
| 1991 |
Riegel AT, Lu Y, Remenick J, Wolford RG, Berard DS, Hager GL. Proopiomelanocortin gene promoter elements required for constitutive and glucocorticoid-repressed transcription. Molecular Endocrinology (Baltimore, Md.). 5: 1973-82. PMID 1791842 DOI: 10.1210/Mend-5-12-1973 |
0.351 |
|
| Show low-probability matches. |